← back to search

Ling Wang

Jiujiang University · CN
Area of research
Pharmacology · Oncology
Research interest
Research interests include Drug Transport and Resistance Mechanisms, Pharmacogenetics and Drug Metabolism, Pharmacological Effects of Natural Compounds, and Plant-based Medicinal Research.
h-index
39
citations
5,267
works
417
NIH funding
primary concept
email

Recent publications

Development and application of a CNS PBPK model that integrates CSF dynamics to optimize dosing regimens of antibacterial agents in pediatric patients with meningitis
International Journal of Antimicrobial Agents 2026cited by 0position: contributordoi
Virtual Bioequivalence Assessment and Dissolution Safe Space Exploration for Fixed-Dose Metformin-Glyburide Tablet Using Physiologically Based Biopharmaceutics Modeling.
2025cited by 0position: contributordoi
A physiologically-based quantitative systems pharmacology model for mechanistic understanding of the response to alogliptin and its application in patients with renal impairment.
2025cited by 0position: contributordoi
A real-world pharmacovigilance study of QT interval prolongation and Torsades de Pointes associated with CDK4/6 inhibitors in breast cancer patients: findings from the FDA adverse event reporting system.
2024cited by 6position: contributordoi
Investigation into the impact of proton pump inhibitors on sertraline transport across the blood-brain barrier
European Journal of Pharmaceutical Sciences 2024cited by 5position: contributordoi
Physiologically Based Pharmacokinetic Modeling to Unravel the Drug-gene Interactions of Venlafaxine: Based on Activity Score-dependent Metabolism by CYP2D6 and CYP2C19 Polymorphisms.
2024cited by 2position: contributordoi
A sensitive, heart-cutting, two-dimensional liquid chromatography–tandem mass spectrometry method for the determination of mometasone furoate in human plasma: Application for a bioequivalence study in nasal spray formulations
Acta Chromatographica 2024cited by 2position: contributordoi
Enhancing Paclitaxel Efficacy with Piperine-Paclitaxel Albumin Nanoparticles in Multidrug-Resistant Triple-Negative Breast Cancer by Inhibiting P-Glycoprotein.
2023cited by 13position: contributordoi
Genome-Wide Association Analysis of Protein-Coding Variants in IgA Nephropathy
Journal of the American Society of Nephrology 2023cited by 10position: middledoi
Physiologically Based Pharmacokinetic Modeling to Simulate CYP3A4-Mediated Drug-Drug Interactions for Pyrotinib.
2023cited by 3position: contributordoi
Evaluation of Safety of Treatment With Anti–Epidermal Growth Factor Receptor Antibody Drug Conjugate MRG003 in Patients With Advanced Solid Tumors
JAMA Oncology 2022cited by 68position: middledoi
Changes in target ability of nanoparticles due to protein corona composition and disease state.
2022cited by 25position: contributordoi
Targeted inhibition of FcRn reduces NET formation to ameliorate experimental ulcerative colitis by accelerating ANCA clearance.
2022cited by 19position: contributordoi
Silymarin Protects against Acute Liver Injury Induced by Acetaminophen by Downregulating the Expression and Activity of the CYP2E1 Enzyme.
2022cited by 17position: contributordoi
Physiologically based pharmacokinetic modeling of brivaracetam and its interactions with rifampin based on CYP2C19 phenotypes.
2022cited by 14position: contributordoi
The Addition of Ferritin Enhanced the Prognostic Value of International Prognostic Index in Diffuse Large B‐Cell Lymphoma
Frontiers in Oncology 2022cited by 13position: middledoi
Tanshinone IIA prevents acetaminophen-induced nephrotoxicity through the activation of the Nrf2-Mrp2/4 pathway in mice.
2022cited by 6position: contributordoi
Tanshinone IIA alleviate rifampicin-induced cholestasis by regulating the expression and function of bile salt export pump.
2022cited by 3position: contributordoi
Physiologically based pharmacokinetic modeling of tramadol to inform dose adjustment and drug-drug interactions according to CYP2D6 phenotypes.
2021cited by 15position: contributordoi
Physiologically Based Pharmacokinetic Modeling in Pregnant Women Suggests Minor Decrease in Maternal Exposure to Olanzapine.
2021cited by 15position: contributordoi
Dose Adjustment of Quetiapine and Aripiprazole for Pregnant Women Using Physiologically Based Pharmacokinetic Modeling and Simulation.
2021cited by 13position: contributordoi
Pipette-tip micro-solid phase extraction based on melamine-foam@polydopamine followed by ultra-high-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry for detection of psychotropic drugs in human serum.
2021cited by 6position: contributordoi
Assessing CYP2C8-Mediated Pharmaceutical Excipient-Drug Interaction Potential: A Case Study of Tween 80 and Cremophor EL-35.
2021cited by 6position: contributordoi
Quantitation of Apremilast in Beagle Dogs Plasma by UPLC-MS-MS and Its Application to Pharmacokinetic Studies.
2021cited by 2position: contributordoi
A rapid and sensitive High-Performance Liquid Chromatography-tandem Mass Spectrometry method for determining apremilast in beagle dog plasma and urine: Application in a pharmacokinetic study
Acta Chromatographica 2021cited by 0position: contributordoi
Enhanced Cancer-targeted Drug Delivery Using Precoated Nanoparticles.
2020cited by 51position: contributordoi
The diverse functions of Siglec-15 in bone remodeling and antitumor responses
Pharmacological Research 2020cited by 42position: middledoi
Tanshinone IIA prevents rifampicin-induced liver injury by regulating BSEP/NTCP expression via epigenetic activation of NRF2.
2020cited by 28position: contributordoi
Tanshinone IIA attenuates acetaminophen-induced hepatotoxicity through HOTAIR-Nrf2-MRP2/4 signaling pathway.
2020cited by 16position: contributordoi
Metabolite identification, tissue distribution, excretion and preclinical pharmacokinetic studies of ET-26-HCl, a new analogue of etomidate.
2020cited by 4position: contributordoi

Grants

Deep Learning for Survival Analysis, Causal Inference, and Conformal Inference,
NSF2413924$250,0002024–2027PIRePORTER
Testing and Deep Learning for Functional Data
NSF2210891$299,9972022–2025PIRePORTER
Modeling and Radiosonde Data Investigations of Turbulence and Mixing in the Vicinity of the Tropopause
NSF2032678$359,9572021–2023PIRePORTER
Collaborative Research: Processes Determining the Climatology of Atmospheric Unstable Layers
NSF2129222$117,7462021–2025PIRePORTER
Complex Problems in Functional Data Analysis
NSF1914917$200,0002019–2023PIRePORTER
Collaborative Research: Modeling the Nonlinear Dynamics of Deep Gravity Waves in the Mesosphere and Thermosphere
NSF1758293$251,1242018–2021PIRePORTER
Atmospheric Turbulence - Detailed Modeling and Characterization from Radosonde Observations
NSF1510354$302,0252015–2020PIRePORTER
Functional Data Analysis: From Univariate to High-Dimensional Functional Data
NSF1512975$179,9992015–2019PIRePORTER
New Directions in Functional Data Analysis
NSF0906813$399,6272009–2015PIRePORTER
Wave Characteristics from the COSMIC and CHAMP Global Positioning System (GPS) Temperature Profiles
NSF0737692$244,0982007–2010PIRePORTER
Functional Analysis of Sparse Longitudinal Data
NSF0406430$374,5222004–2009PIRePORTER
Statistical Modelling and Dimension Reduction for Functional Data
NSF9803627$64,0011998–2003PIRePORTER
Mathematical Sciences: Innovative Statistical Methods for Biological Life Spans and Oldest-Old Mortality
NSF9404906$86,3101995–1998PIRePORTER
Mathematical Sciences: Some Problems for Incomplete Survival Data
NSF9312170$60,0001994–1997PIRePORTER

Frequent collaborators

· 25 papers (2019–2026)Ting Wang · Anhui Mental Health Center3 papers (2019–2022)Liang Zheng · Sichuan University3 papers (2021–2023)Chaozhuang Shen · Shandong University2 papers (2025–2026)Wenwen Xu · Wannan Medical College2 papers (2021–2023)Huile Gao · Peking University2 papers (2020–2022)Meng Zhang · Second Affiliated Hospital of Nanchang University1 papers (2022–2022)Hu Li · Nanjing Medical University1 papers (2022–2022)Shuo Zhang · North China University of Science and Technology1 papers (2022–2022)Lihong Liu · Hebei Medical University1 papers (2016–2016)Jinglin Li · Harbin Medical University1 papers (2017–2017)Sisi Li · Anhui Medical University1 papers (2017–2017)Yingze Zhang · Hebei Medical University1 papers (2020–2020)Lin Dong · State Key Laboratory of Pollution Control and Resource Reuse1 papers (2017–2017)Chunli Wang · East China University of Science and Technology1 papers (2017–2017)Ying Gong · Shandong University1 papers (2017–2017)Yuanyuan Luo · Kunming University of Science and Technology1 papers (2017–2017)Wenxue Zhang · Nankai University1 papers (2022–2022)Weiying Gu · Soochow University1 papers (2022–2022)Rui‐Hua Xu · Henan Medical University1 papers (2022–2022)